Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
|
Mid-range Performer
1094.4000
-14.80
(
-1.33
%)
NSE
Sep 12, 2025
15:31 PM
30.91% Fall from 52W High
Volume:
794.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
15 Aug 2023
1094.40
-1.33%
Aurobindo Pharma (HOLD): Broad-based growth; lower to HOLD post rally
Hold:
Aurobindo Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 880
Recommendation
Target
BOB Capital Markets Ltd.
Q1 revenue/EBITDA beat consensus by 4%/9% with adj. PAT (ex-one-off charge) running 15% ahead
Aurobindo Pharma Ltd. is trading
below its 100 day SMA
of 1132.4
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - September 12, 2025
The Baseline |
12 Sep 2025, 04:39PM
Market closes higher, Hindustan Copper announces a Rs 2,000 crore capex
Trendlyne Marketwatch |
12 Sep 2025, 04:00PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020